Sisay Desale
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sisay Desale has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Afewerk Habtamu
School of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia
5 shared publications - Saleamlak Sebsibe
Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia
5 shared publications - Mahider Shimelis Feyisa
School of Medical Laboratory Sciences, Asrat Weldeyes Health Science Campus Debre Berhan University Debre Berhan Ethiopia
3 shared publications - Mikiyas Shemelis Achame
School of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia
3 shared publications - Zewudu Mulatie
Department of Medical Laboratory Sciences, College of Medicine and Health Sciences Wollo University Dessie Ethiopia
3 shared publications Amanuel Mengesha
2 shared publications
Latest Publications
- Open Access
- 18 November 2026
- Published by Springer Nature in BMC Pediatrics
Effect of phototherapy on serum electrolyte levels among neonates with hyperbilirubinemia: a systematic review and meta-analysis
- 18 November 2026
- Published by Springer Nature in BMC Pediatrics
Open AccessEffect of phototherapy on serum electrolyte levels among neonates with hyperbilirubinemia: a systematic review and meta-analysis
- Open Access
- 7 October 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (10) , e73354
Blood Unit Discard Rates Due to Transfusion–Transmissible Infections and Non‐Infectious Causes and Their Associated Factors in Eastern and Northeastern Parts of Amhara Regional State, Ethiopia: A Retrospective Cross‐Sectional Study From 2022–2025
Background: Blood is an irreplaceable medical resource, yet blood unit discard remains a significant challenge for transfusion services. This study aimed to evaluate discard rates by integrating both infectious (TTI) and non‐infectious causes and identifying factors associated with blood wastage to provide evidence to support strategies for improving blood safety. Methods: An institutional‐based retrospective cross‐sectional study was conducted using data from 2022 to 2025 across Dessie, Kemise, Woldia, and Sekota Blood Banks. Data were extracted from Blood Bank databases using a structured checklist and analyzed with SPSS version 26.0. Both univariable and Multivariable logistic regression were performed to identify predictors of transfusion transmissible infections (TTIs) and non‐infectious causes, with statistical significance set at p < 0.05. Results: Records from 60,008 donors and 67,976 blood products were reviewed. A total of 6,130 units (9.02%) were discarded. TTIs accounted for 4.6% of discards, led by Hepatitis B virus (2.0%) and Syphilis (1.2%). Non‐infectious causes contributed 4.4%, primarily due to expiration (2.0%). ABO group, Rh factor, donor age, donor type, collection site, and Blood Bank location were identified as significant predictors of discard. Conclusion: The study reveals a notable blood unit discard rate of 9.02%, driven equally by infectious transfusion‐transmissible infections and non‐infectious factors like expiration. Key risk factors include donor demographics, blood group, and specific blood bank locations, highlighting the need for better inventory management and targeted donor selection.
- 7 October 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (10) , e73354
Open AccessBlood Unit Discard Rates Due to Transfusion–Transmissible Infections and Non‐Infectious Causes and Their Associated Factors in Eastern and Northeastern Parts of Amhara Regional State, Ethiopia: A Retrospective Cross‐Sectional Study From 2022–2025
Background: Blood is an irreplaceable medical resource, yet blood unit discard remains a significant challenge for transfusion services. This study aimed to evaluate discard rates by integrating both infectious (TTI) and non‐infectious causes and identifying factors associated with blood wastage to provide evidence to support strategies for improving blood safety. Methods: An institutional‐based retrospective cross‐sectional study was conducted using data from 2022 to 2025 across Dessie, Kemise, Woldia, and Sekota Blood Banks. Data were extracted from Blood Bank databases using a structured checklist and analyzed with SPSS version 26.0. Both univariable and Multivariable logistic regression were performed to identify predictors of transfusion transmissible infections (TTIs) and non‐infectious causes, with statistical significance set at p < 0.05. Results: Records from 60,008 donors and 67,976 blood products were reviewed. A total of 6,130 units (9.02%) were discarded. TTIs accounted for 4.6% of discards, led by Hepatitis B virus (2.0%) and Syphilis (1.2%). Non‐infectious causes contributed 4.4%, primarily due to expiration (2.0%). ABO group, Rh factor, donor age, donor type, collection site, and Blood Bank location were identified as significant predictors of discard. Conclusion: The study reveals a notable blood unit discard rate of 9.02%, driven equally by infectious transfusion‐transmissible infections and non‐infectious factors like expiration. Key risk factors include donor demographics, blood group, and specific blood bank locations, highlighting the need for better inventory management and targeted donor selection.
- Open Access
- 1 October 2026
- Published by Springer Nature in BMC Women's Health
Molecular epidemiology of cervical high-risk human papillomavirus infection in Ethiopia (2000–2026): a systematic review and meta-analysis
- 1 October 2026
- Published by Springer Nature in BMC Women's Health
Open AccessMolecular epidemiology of cervical high-risk human papillomavirus infection in Ethiopia (2000–2026): a systematic review and meta-analysis
- Open Access
- 15 September 2026
- Published by Springer Nature in BMC Endocrine Disorders
Association between high-sensitivity C-reactive protein and metabolic syndrome: systematic review and meta-analysis
Background: Metabolic syndrome (MetS) is a cluster of cardiometabolic abnormalities associated with chronic low-grade systemic inflammation. High-sensitivity C-reactive protein (hs-CRP) is a sensitive biomarker of inflammation and has been proposed as a potential indicator of MetS. However, the magnitude of the association between hs-CRP and MetS remains inconsistent across populations. This systematic review and meta-analysis aimed to quantify the difference in hs-CRP levels between individuals with and without MetS. Methods: A systematic search of PubMed/MEDLINE, EMBASE, Scopus, Web of Science, Cochrane Library, Epistemonikos, and gray literature sources was conducted. Eligible observational studies reporting mean and standard deviation of hs-CRP among participants with and without MetS were included. Data were pooled using a random-effects model, and standardized mean differences (SMDs) with 95% confidence intervals (CIs) were calculated. Subgroup analyses were performed according to geographic region, study design, study setting, fasting status, hs-CRP assay type, and MetS diagnostic criteria. Results: Twenty-eight studies involving 71,882 participants (23,945 MetS cases and 47,937 controls) were included. Overall, hs-CRP levels were significantly higher among individuals with MetS than among healthy controls (SMD = 0.95, 95% CI: 0.81–1.10; p < 0.001). Significant heterogeneity was observed across studies (I² = 99.49%, p < 0.001). Subgroup analyses demonstrated higher effect estimates in Europe (SMD = 2.84) and Africa (SMD = 2.63) compared with Asia and the Middle East. The association remained significant across study designs, settings, assay methods, and MetS diagnostic criteria. Conclusions: People with metabolic syndrome had greater levels of hs-CRP than people without the condition. However, causal interpretation is constrained by the observational nature of the available data and significant between-study heterogeneity. To ascertain the temporal connection between hs-CRP and metabolic syndrome, prospective longitudinal studies are required.
- 15 September 2026
- Published by Springer Nature in BMC Endocrine Disorders
Open AccessAssociation between high-sensitivity C-reactive protein and metabolic syndrome: systematic review and meta-analysis
Background: Metabolic syndrome (MetS) is a cluster of cardiometabolic abnormalities associated with chronic low-grade systemic inflammation. High-sensitivity C-reactive protein (hs-CRP) is a sensitive biomarker of inflammation and has been proposed as a potential indicator of MetS. However, the magnitude of the association between hs-CRP and MetS remains inconsistent across populations. This systematic review and meta-analysis aimed to quantify the difference in hs-CRP levels between individuals with and without MetS. Methods: A systematic search of PubMed/MEDLINE, EMBASE, Scopus, Web of Science, Cochrane Library, Epistemonikos, and gray literature sources was conducted. Eligible observational studies reporting mean and standard deviation of hs-CRP among participants with and without MetS were included. Data were pooled using a random-effects model, and standardized mean differences (SMDs) with 95% confidence intervals (CIs) were calculated. Subgroup analyses were performed according to geographic region, study design, study setting, fasting status, hs-CRP assay type, and MetS diagnostic criteria. Results: Twenty-eight studies involving 71,882 participants (23,945 MetS cases and 47,937 controls) were included. Overall, hs-CRP levels were significantly higher among individuals with MetS than among healthy controls (SMD = 0.95, 95% CI: 0.81–1.10; p < 0.001). Significant heterogeneity was observed across studies (I² = 99.49%, p < 0.001). Subgroup analyses demonstrated higher effect estimates in Europe (SMD = 2.84) and Africa (SMD = 2.63) compared with Asia and the Middle East. The association remained significant across study designs, settings, assay methods, and MetS diagnostic criteria. Conclusions: People with metabolic syndrome had greater levels of hs-CRP than people without the condition. However, causal interpretation is constrained by the observational nature of the available data and significant between-study heterogeneity. To ascertain the temporal connection between hs-CRP and metabolic syndrome, prospective longitudinal studies are required.
- Open Access
- 9 July 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Burden of Epstein-Barr virus in gastric cancer, nasopharyngeal carcinoma, and Burkitt lymphoma in Africa: a systematic review and meta-analysis
Epstein-Barr virus (EBV) is implicated in nasopharyngeal carcinoma (NPC), gastric cancer (GC), and Burkitt lymphoma (BL), but its burden across Africa rema
- 9 July 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessBurden of Epstein-Barr virus in gastric cancer, nasopharyngeal carcinoma, and Burkitt lymphoma in Africa: a systematic review and meta-analysis
Epstein-Barr virus (EBV) is implicated in nasopharyngeal carcinoma (NPC), gastric cancer (GC), and Burkitt lymphoma (BL), but its burden across Africa rema
- Open Access
- 5 May 2026
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 20 (5) , e0013703
Accuracy of AI-assisted diagnostic tools for Schistosoma haematobium: A systematic review and meta-analysis
Background: Urogenital schistosomiasis caused by Schistosoma haematobium remains endemic in sub-Saharan Africa. Diagnosis traditionally relies on urine microscopy to detect parasite eggs; however, its sensitivity declines in low-intensity infections. Artificial intelligence (AI)-assisted image analysis offers a promising approach to automate egg detection and enhance diagnostic accuracy, but its performance compared with standard microscopy is not well established. Methods: We conducted a systematic review following the PRISMA guidelines and checklist. Studies evaluating AI-assisted detection of S. haematobium compared with microscopy and/or molecular reference standards, published up to August 2025, were identified through searches in PubMed/MEDLINE, HINARI, Epistemonikos, Science Direct, Google Scholar and grey literature sources. Eligible studies were selected based on pre-defined inclusion and exclusion criteria. The quality of included studies was assessed using the QUADAS-2 tool. Heterogeneity among studies was evaluated using the Cochrane Q test and I² statistic. Data was analyzed using STATA version 14.1 and Review Manager version 5.4.1. Results: Ten studies (15 datasets, 5,564 urine samples) conducted in sub-Saharan Africa met the inclusion criteria. AI-assisted tools demonstrated high diagnostic accuracy. The pooled sensitivity was 88% (95%CI 83%-91%) and pooled specificity was 89% (95% CI 83%-93%). The pooled diagnostic odds ratio was 54.00 (95% CI 30.41-95.88), indicating strong discrimination between infected and uninfected cases. The SROC curve yielded an AUC of 0.94 (95% CI 0.92-0.96), reflecting excellent overall accuracy. Heterogeneity across studies was high (I² = 100%), suggesting results varied by the specific AI platform and study context. Conclusion: AI-assisted microscopic diagnosis of S. haematobium achieved very good in this meta-analysis. These automated tools, whether smartphone-based or bench-top systems, showed promise for detecting infections and could help screen populations in endemic areas. With further validation in field settings and comparison to highly sensitive reference tests, AI diagnostic technology may become a valuable tool to improve case detection and support schistosomiasis control and elimination efforts.
- 5 May 2026
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 20 (5) , e0013703
Open AccessAccuracy of AI-assisted diagnostic tools for Schistosoma haematobium: A systematic review and meta-analysis
Background: Urogenital schistosomiasis caused by Schistosoma haematobium remains endemic in sub-Saharan Africa. Diagnosis traditionally relies on urine microscopy to detect parasite eggs; however, its sensitivity declines in low-intensity infections. Artificial intelligence (AI)-assisted image analysis offers a promising approach to automate egg detection and enhance diagnostic accuracy, but its performance compared with standard microscopy is not well established. Methods: We conducted a systematic review following the PRISMA guidelines and checklist. Studies evaluating AI-assisted detection of S. haematobium compared with microscopy and/or molecular reference standards, published up to August 2025, were identified through searches in PubMed/MEDLINE, HINARI, Epistemonikos, Science Direct, Google Scholar and grey literature sources. Eligible studies were selected based on pre-defined inclusion and exclusion criteria. The quality of included studies was assessed using the QUADAS-2 tool. Heterogeneity among studies was evaluated using the Cochrane Q test and I² statistic. Data was analyzed using STATA version 14.1 and Review Manager version 5.4.1. Results: Ten studies (15 datasets, 5,564 urine samples) conducted in sub-Saharan Africa met the inclusion criteria. AI-assisted tools demonstrated high diagnostic accuracy. The pooled sensitivity was 88% (95%CI 83%-91%) and pooled specificity was 89% (95% CI 83%-93%). The pooled diagnostic odds ratio was 54.00 (95% CI 30.41-95.88), indicating strong discrimination between infected and uninfected cases. The SROC curve yielded an AUC of 0.94 (95% CI 0.92-0.96), reflecting excellent overall accuracy. Heterogeneity across studies was high (I² = 100%), suggesting results varied by the specific AI platform and study context. Conclusion: AI-assisted microscopic diagnosis of S. haematobium achieved very good in this meta-analysis. These automated tools, whether smartphone-based or bench-top systems, showed promise for detecting infections and could help screen populations in endemic areas. With further validation in field settings and comparison to highly sensitive reference tests, AI diagnostic technology may become a valuable tool to improve case detection and support schistosomiasis control and elimination efforts.
- Open Access
Accuracy of AI-assisted diagnostic tools for Schistosoma haematobium : A systematic review and meta-analysis
Background: Urogenital schistosomiasis caused by Schistosoma haematobium remains endemic in sub-Saharan Africa. Diagnosis traditionally relies on urine microscopy to detect parasite eggs; however, its sensitivity declines in low-intensity infections. Artificial intelligence (AI)-assisted image analysis offers a promising approach to automate egg detection and enhance diagnostic accuracy, but its performance compared with standard microscopy is not well established. Methods: We conducted a systematic review following the PRISMA guidelines and checklist. Studies evaluating AI-assisted detection of S. haematobium compared with microscopy and/or molecular reference standards, published up to August 2025, were identified through searches in PubMed/MEDLINE, HINARI, Epistemonikos, Science Direct, Google Scholar and grey literature sources. Eligible studies were selected based on pre-defined inclusion and exclusion criteria. The quality of included studies was assessed using the QUADAS-2 tool. Heterogeneity among studies was evaluated using the Cochrane Q test and I² statistic. Data were analyzed using STATA version 14.1 and Review Manager version 5.4.1. Results: A total of ten studies comprising 18 datasets and 7,318 participants met the eligibility criteria. The pooled sensitivity and specificity of AI-assisted diagnostic tools compared with standard microscopy were 0.88 (95% CI: 0.84–0.92) and 0.89 (95% CI: 0.85–0.93), respectively. The pooled diagnostic odds ratio (DOR) was 64 (95% CI: 38–106), and the area under the summary receiver operating characteristic curve (AUC) was 0.95 (95% CI: 0.92–0.96). The positive likelihood ratio (PLR) was 28.86 (95% CI: 12.01– 67.00), while the negative likelihood ratio (NLR) was 0.03 (95% CI: 0.01–0.10). Subgroup analysis revealed higher diagnostic accuracy of AI-assisted tools in community surveys (sensitivity = 0.93, specificity = 0.90) and superior pooled performance for AiDx platforms (sensitivity = 0.93, specificity = 0.91) compared with SchistoScope (sensitivity = 0.86, specificity = 0.86). Overall, substantial heterogeneity was observed across studies (I² = 99%). Conclusion: AI-assisted diagnostic tools demonstrate high accuracy for detecting S. haematobium and could serve as valuable complements to existing diagnostic approaches. However, further field validation, standardization and integration into routine diagnostic workflows are needed to ensure their reliability and scalability in real-world settings.
Open AccessAccuracy of AI-assisted diagnostic tools for Schistosoma haematobium : A systematic review and meta-analysis
Background: Urogenital schistosomiasis caused by Schistosoma haematobium remains endemic in sub-Saharan Africa. Diagnosis traditionally relies on urine microscopy to detect parasite eggs; however, its sensitivity declines in low-intensity infections. Artificial intelligence (AI)-assisted image analysis offers a promising approach to automate egg detection and enhance diagnostic accuracy, but its performance compared with standard microscopy is not well established. Methods: We conducted a systematic review following the PRISMA guidelines and checklist. Studies evaluating AI-assisted detection of S. haematobium compared with microscopy and/or molecular reference standards, published up to August 2025, were identified through searches in PubMed/MEDLINE, HINARI, Epistemonikos, Science Direct, Google Scholar and grey literature sources. Eligible studies were selected based on pre-defined inclusion and exclusion criteria. The quality of included studies was assessed using the QUADAS-2 tool. Heterogeneity among studies was evaluated using the Cochrane Q test and I² statistic. Data were analyzed using STATA version 14.1 and Review Manager version 5.4.1. Results: A total of ten studies comprising 18 datasets and 7,318 participants met the eligibility criteria. The pooled sensitivity and specificity of AI-assisted diagnostic tools compared with standard microscopy were 0.88 (95% CI: 0.84–0.92) and 0.89 (95% CI: 0.85–0.93), respectively. The pooled diagnostic odds ratio (DOR) was 64 (95% CI: 38–106), and the area under the summary receiver operating characteristic curve (AUC) was 0.95 (95% CI: 0.92–0.96). The positive likelihood ratio (PLR) was 28.86 (95% CI: 12.01– 67.00), while the negative likelihood ratio (NLR) was 0.03 (95% CI: 0.01–0.10). Subgroup analysis revealed higher diagnostic accuracy of AI-assisted tools in community surveys (sensitivity = 0.93, specificity = 0.90) and superior pooled performance for AiDx platforms (sensitivity = 0.93, specificity = 0.91) compared with SchistoScope (sensitivity = 0.86, specificity = 0.86). Overall, substantial heterogeneity was observed across studies (I² = 99%). Conclusion: AI-assisted diagnostic tools demonstrate high accuracy for detecting S. haematobium and could serve as valuable complements to existing diagnostic approaches. However, further field validation, standardization and integration into routine diagnostic workflows are needed to ensure their reliability and scalability in real-world settings.